Siemens Healthineers has unveiled its latest innovation in coagulation diagnostics with the launch of the CN-3000 and CN-6000 Hemostasis Systems in Canada, following recent Health Canada approval. These advanced analyzers are designed to support both routine and specialty coagulation testing, offering laboratories a powerful and flexible solution to detect and manage bleeding and thrombotic disorders. With a broad test menu and high analytical precision, the systems are purpose-built to streamline workflows and deliver faster, more accurate results—enabling timely, confident clinical decisions in critical care settings.

The CN-3000 and CN-6000 systems mark a significant advancement in automated hemostasis testing, combining high-throughput performance with intelligent system design. Both platforms are equipped to handle increasing diagnostic volumes while maintaining consistent quality and reliability. Their seamless integration with Atellica Data Manager (ADM) and Atellica Process Manager (APM) further enables fully automated, hands-free workflows. Features such as real-time analytics, centralized monitoring, and automated sample routing allow labs to operate more efficiently, reduce manual errors, and maintain standardized protocols across multiple sites and instruments.

This launch reflects Siemens Healthineers' ongoing commitment to transforming laboratory diagnostics through innovation and automation. By enhancing testing accuracy and operational scalability, the CN-3000 and CN-6000 systems not only address current laboratory challenges but also position labs for future growth. As healthcare systems increasingly demand faster turnaround times, integrated data solutions, and precision diagnostics, these hemostasis systems represent a forward-looking investment—empowering labs to meet evolving clinical and operational demands while improving outcomes for patients with complex coagulation disorders.